Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995 - Comparison of HIV-associated cases to other immunocompromised states
Ng. Mansharamani et al., Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995 - Comparison of HIV-associated cases to other immunocompromised states, CHEST, 118(3), 2000, pp. 704-711
Citations number
43
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Study objectives: Encompassing periods preceding and following major advanc
es in the diagnosis and management of HIV-related Pneumocystis carinii pneu
monia (PCP), the purpose of this study was to determine whether management
and outcome patterns of non-HIV PCP parallel the management and outcomes of
AIDS-related PCP.
Design: Retrospective review of medical records.
Setting: A 375-bed tertiary-care urban teaching hospital and referral cente
r.
Patients: All adult patients with morphologically confirmed PCP from 1985 t
o 1995.
Measurements and results: From 1985 to 1995, 638 confirmed cases of PCP wer
e identified, including 605 cases in 442 HIV-positive persons (HIV + PCP),
and 33 cases in 33 non-HIV patients (non-HIV PCP). For HIV + PCP cases, a p
eak of 104 cases occurred in 1987, with a gradual decline to 23 in 1995. Th
e proportion of cases requiring hospitalization declined from a peak of 91.
6% in 1987 to a low of 51.6% in 1992. ICU admission was required for 6.3 to
8.2%, and mechanical ventilation for 4.7 to 5.7%. Overall mortality improv
ed from 11.7 to 6.6%, although mortality for intubated patients remained at
50 to 60%. For the non-HIV PCP cases, 97% occurred from 1989 to 1995 with
similar annual frequency, 97% required hospitalization, 69% required ICU ad
mission, and 66% required intubation. Overall mortality was 39%, and mortal
ity for intubated patients was 59%.
Conclusions: Despite major advances in diagnosis and management, PCP remain
s a significant problem in non-HIV-infected patients, and respiratory failu
re remains associated with a high mortality rate for patients with bot HIV
+ PCP and non-HIV PCP.